Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis

NCT04325932 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Intracranial Arteriosclerosis
Collateral Circulation
Anterior Cerebral Circulation Infarction

Interventions

DRUG: Urinary Kallikrein

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University